ESSA Pharma Inc. (EPIX): Price and Financial Metrics
EPIX Price/Volume Stats
| Current price | $6.02 | 52-week high | $11.67 |
| Prev. close | $6.23 | 52-week low | $2.85 |
| Day low | $5.90 | Volume | 53,600 |
| Day high | $6.41 | Avg. volume | 88,251 |
| 50-day MA | $5.73 | Dividend yield | N/A |
| 200-day MA | $6.79 | Market Cap | 267.07M |
EPIX Stock Price Chart Interactive Chart >
ESSA Pharma Inc. (EPIX) Company Bio
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that is in Phase 1/2 clinical trial, which blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is based in Vancouver, Canada.
EPIX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...